CC Pharma Nordic ApS is a Danish-based company engaged in marketing and distribution of parallel imported- and unlicensed medicines within different therapeutic areas to pharmacies and hospitals in the Nordic countries.
Our goal is to create value for patients and society by providing safe and affordable medicines and secure unmet medical needs.
CC Pharma Nordic ApS was founded in 2018 and partly privately owned by co-founder Mr. Steffen Baadsgaard Bruun, who serves as CEO, and Mr. Bo Tandrup, who serves as a member of the board of directors and partly owned subsidiary under CC Pharma GmbH in Germany.
CC Pharma GmbH was founded in 1999 and is now one of the leading companies within marketing and distribution of parallel imported medicines in Germany with approximately 300 employees and in-house production facilities.
CC Pharma GmbH is ultimately owned by Tilray Inc, which is one of the largest cannabis companies in the world.
All activities performed internally and externally are carried out in accordance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP).